Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Sars-Cov-2 Is a Culprit for Some, But Not All Acute Ischemic Strokes: A Report From the Multinational Covid-19 Stroke Study Group Publisher



Shahjouei S1 ; Anyaehie M1 ; Koza E2 ; Tsivgoulis G3 ; Naderi S4 ; Mowla A1, 5 ; Avula V1 ; Sadr AV6 ; Chaudhary D1 ; Farahmand G7 ; Griessenauer C1, 8 ; Azarpazhooh MR9 ; Misra D10 ; Li J11 Show All Authors
Authors
  1. Shahjouei S1
  2. Anyaehie M1
  3. Koza E2
  4. Tsivgoulis G3
  5. Naderi S4
  6. Mowla A1, 5
  7. Avula V1
  8. Sadr AV6
  9. Chaudhary D1
  10. Farahmand G7
  11. Griessenauer C1, 8
  12. Azarpazhooh MR9
  13. Misra D10
  14. Li J11
  15. Abedi V11, 12
  16. Zand R1
Show Affiliations
Authors Affiliations
  1. 1. Neurology Department, Neuroscience Institute, Geisinger Health System, Danville, 17822, PA, United States
  2. 2. Neuroscience Institute, Geisinger Commonwealth School of Medicine, Scranton, 18510, PA, United States
  3. 3. Second Department of Neurology, “Attikon� University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, 12462, Greece
  4. 4. Department of Neurosurgery, Tehran University of Medical Sciences, Tehran, 14155-6559, Iran
  5. 5. Division of Stroke and Endovascular Neurosurgery, Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, 90033, CA, United States
  6. 6. Department de Physique Theorique and Center for Astroparticle Physics, University Geneva, Geneva, 1211, Switzerland
  7. 7. Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, 14155-6559, Iran
  8. 8. Research Institute of Neurointervention, Paracelsus Medical University, Salzburg, 5020, Austria
  9. 9. Department of Clinical Neurological Sciences, Western University, London, N6A 3K7, ON, Canada
  10. 10. Steele Institute of Health and Innovation, Geisinger Health System, Danville, 17822, PA, United States
  11. 11. Department of Molecular and Functional Genomics, Geisinger Health System, Danville, 17822, PA, United States
  12. 12. Biocomplexity Institute, Virginia Tech, Blacksburg, 24060, VA, United States

Source: Journal of Clinical Medicine Published:2021


Abstract

Background. SARS-CoV-2 infected patients are suggested to have a higher incidence of thrombotic events such as acute ischemic strokes (AIS). This study aimed at exploring vascular comorbidity patterns among SARS-CoV-2 infected patients with subsequent stroke. We also investi-gated whether the comorbidities and their frequencies under each subclass of TOAST criteria were similar to the AIS population studies prior to the pandemic. Methods. This is a report from the Multinational COVID-19 Stroke Study Group. We present an original dataset of SASR-CoV-2 infected patients who had a subsequent stroke recorded through our multicenter prospective study. In addi-tion, we built a dataset of previously reported patients by conducting a systematic literature review. We demonstrated distinct subgroups by clinical risk scoring models and unsupervised machine learning algorithms, including hierarchical K-Means (ML-K) and Spectral clustering (ML-S). Results. This study included 323 AIS patients from 71 centers in 17 countries from the original dataset and 145 patients reported in the literature. The unsupervised clustering methods suggest a distinct cohort of patients (ML-K: 36% and ML-S: 42%) with no or few comorbidities. These patients were more than 6 years younger than other subgroups and more likely were men (ML-K: 59% and ML-S: 60%). The majority of patients in this subgroup suffered from an embolic-appearing stroke on imaging (ML-K: 83% and ML-S: 85%) and had about 50% risk of large vessel occlusions (ML-K: 50% and ML-S: 53%). In addition, there were two cohorts of patients with large-artery atherosclerosis (ML-K: 30% and ML-S: 43% of patients) and cardioembolic strokes (ML-K: 34% and ML-S: 15%) with consistent comorbidity and imaging patterns. Binominal logistic regression demonstrated that ischemic heart disease (odds ratio (OR), 4.9; 95% confidence interval (CI), 1.6–14.7), atrial fibrillation (OR, 14.0; 95% CI, 4.8–40.8), and active neoplasm (OR, 7.1; 95% CI, 1.4–36.2) were associated with cardioembolic stroke. Conclusions. Although a cohort of young and healthy men with cardioembolic and large vessel occlusions can be distinguished using both clinical sub-grouping and unsupervised clustering, stroke in other patients may be explained based on the existing comorbidities. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Other Related Docs